NuVasive, Inc. total revenue, net income and dynamics of changes in US dollar today
NuVasive, Inc. current income in US dollar. NuVasive, Inc. net income is now 1 799 000 $. These are the main financial indicators of NuVasive, Inc.. The financial report schedule from 30/06/2017 to 30/06/2021 is available online. The financial report on the chart of NuVasive, Inc. allows you to clearly see the dynamics of fixed assets. Information on NuVasive, Inc. net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
294 828 000 $
+0.93 % ↑
1 799 000 $
-87.976 % ↓
31/03/2021
271 249 000 $
-1.284 % ↓
-7 510 000 $
-180.01278 % ↓
31/12/2020
291 807 000 $
+1.21 % ↑
1 692 000 $
-86.0821 % ↓
30/09/2020
295 282 000 $
+1.53 % ↑
5 872 000 $
-46.667 % ↓
30/09/2019
290 835 000 $
-
11 010 000 $
-
30/06/2019
292 105 000 $
-
14 962 000 $
-
31/03/2019
274 776 000 $
-
9 386 000 $
-
31/12/2018
288 327 000 $
-
12 157 000 $
-
30/09/2018
271 301 000 $
-
15 923 000 $
-
30/06/2018
281 564 000 $
-
11 531 000 $
-
31/03/2018
260 522 000 $
-
-27 132 000 $
-
31/12/2017
271 652 000 $
-
23 960 000 $
-
30/09/2017
247 431 000 $
-
33 617 000 $
-
30/06/2017
260 573 000 $
-
12 661 000 $
-
Show:
to
NuVasive, Inc. financial report charts
The dates of the latest financial statements of NuVasive, Inc.: 30/06/2017, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The latest date of the financial report of NuVasive, Inc. is 30/06/2021. Gross profit NuVasive, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit NuVasive, Inc. is 216 548 000 $
NuVasive, Inc. quarterly report dates
Cost of revenue NuVasive, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue NuVasive, Inc. is 78 280 000 $ Total revenue NuVasive, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue NuVasive, Inc. is 294 828 000 $ Operating income NuVasive, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income NuVasive, Inc. is 22 299 000 $
Net income NuVasive, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income NuVasive, Inc. is 1 799 000 $ Current assets NuVasive, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets NuVasive, Inc. is 765 748 000 $ Total assets NuVasive, Inc. refers to the total amount of assets owned by a person or entity. Total assets NuVasive, Inc. is 2 146 473 000 $
30/06/2021
31/03/2021
31/12/2020
30/09/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
216 548 000 $
199 438 000 $
207 179 000 $
210 649 000 $
213 807 000 $
214 526 000 $
200 282 000 $
202 198 000 $
197 141 000 $
204 508 000 $
186 708 000 $
196 261 000 $
181 848 000 $
194 152 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
78 280 000 $
71 811 000 $
84 628 000 $
84 633 000 $
77 028 000 $
77 579 000 $
74 494 000 $
86 129 000 $
74 160 000 $
77 056 000 $
73 814 000 $
75 391 000 $
65 583 000 $
66 421 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
294 828 000 $
271 249 000 $
291 807 000 $
295 282 000 $
290 835 000 $
292 105 000 $
274 776 000 $
288 327 000 $
271 301 000 $
281 564 000 $
260 522 000 $
271 652 000 $
247 431 000 $
260 573 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
290 835 000 $
292 105 000 $
274 776 000 $
288 327 000 $
271 301 000 $
281 564 000 $
260 522 000 $
271 652 000 $
247 431 000 $
260 573 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
22 299 000 $
17 923 000 $
28 572 000 $
30 159 000 $
30 181 000 $
31 843 000 $
24 006 000 $
29 635 000 $
28 327 000 $
31 366 000 $
10 773 000 $
33 523 000 $
31 353 000 $
29 753 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 799 000 $
-7 510 000 $
1 692 000 $
5 872 000 $
11 010 000 $
14 962 000 $
9 386 000 $
12 157 000 $
15 923 000 $
11 531 000 $
-27 132 000 $
23 960 000 $
33 617 000 $
12 661 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
21 764 000 $
22 224 000 $
21 771 000 $
20 404 000 $
18 143 000 $
17 553 000 $
17 575 000 $
17 094 000 $
15 254 000 $
14 856 000 $
14 491 000 $
12 719 000 $
12 720 000 $
12 572 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
272 529 000 $
253 326 000 $
263 235 000 $
265 123 000 $
260 654 000 $
260 262 000 $
250 770 000 $
258 692 000 $
242 974 000 $
250 198 000 $
175 935 000 $
162 738 000 $
150 495 000 $
164 399 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
765 748 000 $
781 560 000 $
1 562 184 000 $
1 521 936 000 $
710 841 000 $
664 310 000 $
606 327 000 $
618 209 000 $
579 653 000 $
571 579 000 $
557 809 000 $
558 990 000 $
529 853 000 $
592 228 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
2 146 473 000 $
2 164 785 000 $
2 693 082 000 $
2 656 571 000 $
1 839 852 000 $
1 805 310 000 $
1 751 102 000 $
1 707 859 000 $
1 675 400 000 $
1 672 337 000 $
1 671 132 000 $
1 639 067 000 $
1 628 916 000 $
1 606 384 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
204 138 000 $
233 857 000 $
856 869 000 $
774 544 000 $
163 399 000 $
128 377 000 $
93 391 000 $
117 840 000 $
75 112 000 $
70 078 000 $
76 135 000 $
72 803 000 $
62 200 000 $
130 932 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
193 115 000 $
184 638 000 $
161 781 000 $
179 460 000 $
168 235 000 $
204 001 000 $
55 000 000 $
-
40 000 000 $
83 302 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
73 741 000 $
72 803 000 $
62 200 000 $
130 932 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
963 238 000 $
942 586 000 $
911 096 000 $
873 334 000 $
871 779 000 $
891 174 000 $
642 716 000 $
-
618 192 000 $
656 834 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
52.35 %
52.21 %
52.03 %
51.14 %
52.03 %
53.29 %
38.46 %
-
37.95 %
40.89 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
840 901 000 $
835 387 000 $
918 918 000 $
899 384 000 $
876 614 000 $
862 724 000 $
840 006 000 $
834 525 000 $
803 621 000 $
781 163 000 $
762 396 000 $
795 309 000 $
755 914 000 $
718 893 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
67 154 000 $
68 956 000 $
24 475 000 $
68 694 000 $
73 271 000 $
40 843 000 $
36 375 000 $
60 093 000 $
51 764 000 $
38 952 000 $
Last revenue report of NuVasive, Inc. was 30/06/2021. According to last financial report total revenue in NuVasive, Inc. was 294 828 000 US dollar and changed by +0.93% since last year. Net income in NuVasive, Inc. was 1 799 000 $ in last quartal, net income changes to -87.976%.
Current cash NuVasive, Inc. - the sum of all of the cash a company has on the date of report. Current cash NuVasive, Inc. is 204 138 000 $
NuVasive, Inc. stocks data
NUVA stock price
NuVasive, Inc. stock price today, NUVA stock quote.
